Trial Profile
A study of SB206 in the treatment of genital warts caused by human papillomavirus.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 Dec 2016
Price :
$35
*
At a glance
- Drugs Berdazimer sodium (Primary)
- Indications Genital warts
- Focus Therapeutic Use
- 05 Dec 2016 New trial record
- 29 Nov 2016 According to a Novan Inc media release, the company plans to initiate this study in the second half of 2017.